Picard Medical, Inc. (PMI) Stock

Picard Medical, Inc. (PMI) is a Healthcare stock trading at $0.18 (as of 2026-06-18), with a market capitalization of $2.14B and a trailing P/E of -0.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc

Valuation — source: SEC EDGAR (first-party)
Price	$0.18
Market Cap	$2.14B
P/E Ratio	-0.2
EV / EBITDA	-0.8
Price / Book	-7.61
Price / Sales	2.01
DCF Value (model)	$-2.81
DCF Upside vs Price	-1669.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$4.94M
Net Margin	-546.6%
Return on Equity	2006.7%
Debt / Equity	-0.69
Current Ratio	0.75
Revenue Growth (YoY)	12.5%
EPS Growth (YoY)	-74.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	-5.86 (distress)

Valuation vs Sector & Industry
Stock P/E	-0.2
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-100.9%
vs Industry	-100.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	CITADEL ADVISORS LLC ($1.74M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Patrick N. J. Schnegelsberg
Employees	75
Country	US
IPO Date	2025-08-22

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.